Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0002085726-25-000008
Filing Date
2025-11-21
Accepted
2025-11-21 16:16:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 11451
  Complete submission text file 0002085726-25-000008.txt   13424
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
CYPHERPUNK TECHNOLOGIES INC. (Subject) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-90188 | Film No.: 251508185
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address FARMERS BANK BUILDING 301 N. MARKET STREET, SUITE 1463 WILIMNGTON DE 19801
Business Address FARMERS BANK BUILDING 301 N. MARKET STREET, SUITE 1463 WILIMNGTON DE 19801 (646) 751-4444
Winklevoss Capital Fund, LLC (Filed by) CIK: 0002085726 (see all company filings)

EIN.: 454617407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A